Advances, Applications, and Translations in Nutrition and Epidemiology
A virtual symposium co-chaired by Frank B. Hu (Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, USA), Miguel A. Martínez-González (University of Navarra, Pamplona, Spain), and Rosa M. Lamuela-Raventós (INSA-University of Barcelona, Barcelona, Spain)

Livestreaming July 1st, 2021
8:00-2:15 pm EST (SPAIN: 14:00-20:15)

Más información y Registro

Agenda

Morning Lectures
[8:00-8:10 am EST (SPAIN: 14:00-14:10)]
Introduction
Frank B. Hu, Harvard T.H. Chan School of Public Health, Boston, USA; Miguel A. Martínez-González, Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBEROBN), University of Navarra, Pamplona, Spain

[8:10-8:25 am EST]
Trials in Cardiovascular Prevention: current status of PREDIMED-Plus
Jordi Salas-Salvadó, CIBEROBN, University Rovira i Virgili, Reus, Spain

[8:25-8:50 am EST]
Polyphenol intake and chronic disease, polyphenols in urine as nutritional biomarkers
Rosa M. Lamuela-Raventós, INSA-CIBEROBN, University of Barcelona, Barcelona, Spain

[8:50-9:15 am EST]
Diet, the microbiome and precision nutrition
Andrew T. Chan, Massachusetts General Hospital, Boston, USA

[9:15-9:30 am EST]
The Spanish CORDIOPREV trial: Mediterranean diet in secondary vascular prevention
Javier Delgado, CIBEROBN, University of Córdoba, Córdoba, Spain

[9:30-9:40 am EST]
Questions & Answers

[9:40 am EST (SPAIN: 15:40)] 10-minute break
[9:50-10:15 am EST]
Dietary metabotype modelling predicts individual responses to dietary interventions
Isabel García-Pérez, Imperial College, London, UK

[10:15-10:40 am EST]
Obesity physiopathology: hypothalamic control of energy and metabolic homeostasis
Carlos Diéguez, CIBEROBN, University of Santiago, Santiago de Compostela, Spain

[10:40-10:55 am EST]
Advances in analytic approaches in multi-fluid, multi-omic analyses & food-based biomarkers
Liming Liang, Harvard T.H. Chan School of Public Health, Boston, USA

[10:55-11:05 am EST]
Plans for starting “IMPaCT”, a large National Cohort in Spain
Miguel A. Martínez-González, CIBEROBN, University of Navarra, Pamplona, Spain

[11:05-11:30 am EST]
Recent developments in metabolomics and food intake biomarkers
David Wishart, University of Alberta, Edmonton, Canada

[11:30-11:45 am EST]
Questions & Answers

[11:45 am EST (SPAIN: 17:45)] 30-minute break
Ongoing analysis and works in progress –  METABOLOMICS & PREDIMED
[12:15–12:28 pm EST]
Urea cycle metabolites and risk of atrial fibrillation and heart failure
Miguel Ruiz-Canela, CIBEROBN, University of Navarra

[12:28–12:40 pm EST]
Changes in metabolomics profiles over ten years and subsequent risk of developing type 2 diabetes: Results from the Nurses’ Health Study
Clemens Wittenbecher, Harvard T.H. Chan School of Public Health & German Institute of Human Nutrition Potsdam-Rehbruecke

[12:40–12:52 pm EST]
Metabolic signature of the Mediterranean diet and cardiometabolic health
Estefanía Toledo, CIBEROBN, University of Navarra

[12:52–1:05 pm EST]
Plasma lipid metabolites and the risk of peripheral artery disease in the PREDIMED study
Xiao Gu, Harvard T.H. Chan School of Public Health

[1:05-1:20 pm EST]
Questions & Answers

[1:20–1:30 pm EST]
Glycolysis/gluconeogenesis- and tricarboxylic acid cycle-related metabolites, Mediterranean diet, and peripheral artery disease
Cristina Razquin, CIBEROBN, University of Navarra

[1:30–1:43 pm EST]
Metabolites and risk of type 2 diabetes: an integrated metabolomics and genetics study pooling ~23,000 participants
Jun Li, Harvard T.H. Chan School of Public Health

[1:43–1:55 pm EST]
Metabolomics profiles associated with the amount and source of meat and fish consumption
Pablo Hernández-Alonso, CIBEROBN, University Rovira i Virgili, Open Evidence

[1:55–2:10 pm EST]
Questions & Answers

[2:10-2:15 pm EST (SPAIN: 20:10-20:15)]
Closing remarks
Frank B. Hu and Miguel A. Martínez-González